- Harmaline
-
- $0.00 / 1kg
-
2024-11-28
- CAS:304-21-2
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000 kg
- Harmaline
-
- $50.00 / 20mg
-
2024-11-19
- CAS:304-21-2
- Min. Order:
- Purity: 99.57%
- Supply Ability: 10g
|
| | HARMALINE Basic information |
| | HARMALINE Chemical Properties |
| Melting point | 232-234 °C(lit.) | | Boiling point | 354.4°C (rough estimate) | | alpha | ±0° | | density | 1.0850 (rough estimate) | | refractive index | 1.6450 (estimate) | | storage temp. | -10 to -25°C | | Water Solubility | Slightly soluble in water | | solubility | DMF: 1.4 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 0.25 mg/ml; Ethanol: 0.5 mg/ml | | form | powder | | pka | 4.2(at 25℃) | | color | Light orange to Yellow to Green | | Merck | 14,4613 | | BRN | 207310 | | LogP | 2.251 (est) | | CAS DataBase Reference | 304-21-2(CAS DataBase Reference) | | NIST Chemistry Reference | Harmaline(304-21-2) | | EPA Substance Registry System | 3H-Pyrido[3,4-b]indole, 4,9-dihydro-7-methoxy-1-methyl- (304-21-2) |
| | HARMALINE Usage And Synthesis |
| Uses | CNS stimulant; may act through NMDA receptors. Reversible inhibitor of MAO-A | | Uses | CNS stimulant, antiparkinsonian agent | | Definition | ChEBI: A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7 and has been reduced across the 3,4 bond. | | Synthesis Reference(s) | Canadian Journal of Chemistry, 37, p. 1851, 1959 DOI: 10.1139/v59-272 | | Biological Activity | CNS stimulant; may act through NMDA receptors | | Purification Methods | Recrystallise harmaline from MeOH and sublime it at high vacuum. It has UV in MeOH a |
| | HARMALINE Preparation Products And Raw materials |
|